Cingulate Inc.

Pharmaceutical company · Kansas City, Kansas, United States · Nasdaq: CING

Cingulate Inc. is a pharmaceutical company headquartered in Kansas City, Kansas, United States. Its earliest recorded incorporation is in 2021. Its shares trade on Nasdaq under the ticker CING.

Profile compiled from public records. Is this your company? Request a correction or update

Cingulate at a glance

Typepharmaceutical company

HeadquartersKansas City, Kansas, United States

Earliest incorporation on record2021

Stock listingNasdaq: CING

SEC industryPharmaceutical Preparations

SEC CIK1862150

What does Cingulate do?

Frequently asked questions about Cingulate

Where is Cingulate headquartered?

Cingulate Inc. is headquartered in Kansas City, Kansas, United States.

What does Cingulate do?

Cingulate Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Cingulate a public company?

Yes. Cingulate Inc. trades on Nasdaq under the ticker CING.

When was Cingulate founded?

The earliest incorporation on record for Cingulate Inc. is in 2021, according to public company registers.

Similar companies

Orbis Biosciences, Inc.Kansas City, Missouri, United States
Cingulate TherapeuticsKansas City, Kansas, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States
Crinetics Pharmaceuticals, Inc.San Diego, California, United States
Cartesian Therapeutics, Inc.Frederick, Maryland, United States
Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
Dare Bioscience, Inc.San Diego, California, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences